Alexion Pharmaceuticals, Inc. · 2 days ago
HCP Physician Marketing Intern, Undergraduate Students
Alexion Pharmaceuticals, Inc. is looking for undergraduate junior and senior level students for a 12-week internship role. The role involves providing operational support for HCP marketing projects and assisting with the execution of national HCP conferences and sales meetings.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Provide operational support for HCP marketing projects, coordinating deliverables, timelines, and the promotional review process
Assist with the execution of fall national HCP conferences, including preparing associated deliverables/promotional materials
Support preparations for a mid-year sales meeting, including material/workshop development and coordination tasks
Manage the HCP team’s weekly tracker to monitor progress and flag timeline challenges
Lead an independent research project requiring cross-functional networking
Qualification
Required
Undergraduate junior and senior level students
No specific major required, but preference will be given to Business, Marketing, or Life Science disciplines
Candidates must have an expected graduation date after August 2026
Ability to demonstrate strong organizational and communication skills, such as coursework in marketing or business, involvement in student organizations, or prior internships/work experience is required
Ability to report onsite to Boston, MA 3-5 days per week
US Work Authorization is required at time of application
This role will not be providing CPT support
Preferred
Exposure to event planning, research projects, collaborative work, managing timelines and coordinating deliverables
Benefits
Short-term incentive bonus opportunity
Equity-based long-term incentive program (salaried roles)
Retirement contribution (hourly roles)
Commission payment eligibility (sales roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage
Company
Alexion Pharmaceuticals, Inc.
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
Funding
Current Stage
Public CompanyTotal Funding
$5.8M2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO
Leadership Team
Recent News
bloomberglaw.com
2025-12-20
Company data provided by crunchbase